Search Results 621-630 of 109201 for b-

  1. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery - Anushka Irani, B.M., B.Ch., Ph.D.

    Anushka Irani, B.M., B.Ch., Ph.D. Senior Associate Consultant, Rheumatology; Research biography. What moment or experience in your life influenced your ...

  2. Publications - Aoife M. Egan, M.B., B.Ch., Ph.D. - Mayo Clinic

    Boscolo F, Mohan S, Laurenti MC, Kohlenberg J, Christie H, Egan AM, Vella A, Dalla Man C. Integrated Glucagon Model for Estimation of Alpha-cell ...

  3. Patient Stories - Andrew McKeon, M.B., B.Ch., M.D. - Mayo Clinic

    Search for a doctor. Andrew McKeon, M.B., B.Ch., M.D.. Neurologist. Request an Appointment · Overview · Patient Stories · News. Patient Stories.

  4. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

    Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia. Participation eligibility.

  5. Publications - Lynne Lillie, M.D. - Mayo Clinic

    Bauer B, Kind S, Lillie L, Johnson E, Gostout B, Weatherby RP, Esch C, Eggen D, Gendron J, Meyer J. Management of Initial Abnormal Pap Smear. ICSI Health ...

  6. A Study to Evaluate the Role of WNT/b-catenin Signaling in Human Alveolar Macrophages (AMs) in Adjusting Inflammation - Mayo Clinic

    The purpose of this study is to determine whether WNT/b-catenin signaling is upregulated in alveolar macrophages (AMs) in children following exposure to common ...

  7. Publications - Daniel B. Grossman, M.D. - Mayo Clinic

    Daniel B. Grossman, M.D.. Emergency Medicine Physician. Request an Appointment · Overview · Publications. Publications. Print. Owusu Isaac, Adomako-Boateng Fred ...

  8. Lymphoma Patients Event-Free Two Years after Diagnosis have a Normal Life Expectancy

    — Feb. 18, 2014 — Newly-diagnosed patients with diffuse large B cell lymphoma (DLBCL) who do not experience any cancer-related outcome events for two years ...

  9. Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) - Mayo Clinic

    Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem ...

  10. Cancer types - Mayo Clinic

    B. C. D. E. F. G ... B. B-cell lymphoma · Basal cell carcinoma · Bladder cancer · Bone cancer · Bone metastasis · Brain metastases · Brain tumor · Brainstem tumor.